nVent Electric vs Relay Therapeutics Inc. Common Stock — how do they compare? nVent Electric trades at $165.74 (market cap $27.16B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: nVent Electric is far larger — about 6.9× Relay Therapeutics Inc. Common Stock's market cap, and nVent Electric pays a 0.5% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold nVent Electric for 11 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NVT | RLAY | |
|---|---|---|
Market Cap | $27.16B | $3.94B |
Volume | 1,530,782 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $184.34 | $20.75 |
52-Week Low | $94.99 | $6.03 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $28.54B | $3.06B |
Dividend Yield | 0.5% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →